US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% SNDK $1,719.99 ▲+0.00% NVDA $233.95 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% MSTR $160.01 ▲+0.00%
FinancialContent

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED
Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more... 
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
From Helus Pharma
Via Business Wire
News headline image
Cybin Initiates At-The-Market Equity Program of up to US$100 Million
From Cybin Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
From Cybin Inc.
Via Business Wire
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
Jefferies sees restrictions around non-recreational psychedelics eventually loosen up. 
Via Stocktwits
Topics Cannabis ETFs Government
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN)Announces Transfer of U.S. Listing to Nasdaq and Ticker Change to HELP
Via Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports Q2 2025 Results and Advances Late-Stage Neuropsychiatry Programs
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Present at Jefferies Global Healthcare Conference in London
Via Investor Brand Network
News headline image
What's Next: Cybin's Earnings Preview ↗
 
Via Benzinga
News headline image
Cybin to Participate in the Jefferies Global Healthcare Conference in London
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sets Nov. 13 Call to Review Q2 Results and Business Update
Via Investor Brand Network
News headline image
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Participate in Guggenheim 2nd Annual Healthcare Innovation Conference
Via Investor Brand Network
News headline image
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Chief Medical Officer to Speak at 2025 Milken Institute Future of Health Summit
Via Investor Brand Network
News headline image
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
From Cybin Inc.
Via Business Wire
News headline image
Cybin Announces Closing of $175 Million Registered Direct Offering
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Closes US$175 Million Registered Direct Offering Led by Top Healthcare Investors
Via Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces US$175M Registered Direct Offering With Warrants Priced at US$6.51
Via Investor Brand Network
News headline image
What's going on in today's pre-market session ↗
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Cybin Announces $175 Million Registered Direct Offering
From Cybin Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
From Pomerantz LLP
Via GlobeNewswire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Highlights Clinical and Regulatory Milestones, Prepares for Upcoming Catalysts
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
From Cybin Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
From Pomerantz LLP
Via GlobeNewswire
News headline image
CYBN Investors Have Opportunity to Join Cybin Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Executives to Present at TD Cowen Neuropsychiatry & Epilepsy Summit
Via Investor Brand Network
News headline image
Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
From Cybin Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >